The findings of this study support the significance of tumor microenvironment elements, such as M2 macrophages, the balance of CD8+ and CD4+ lymphocytes, microvascular density, and epigenetic events, such as BCL6 translocation and p53 expression, in the development of GBM. The gene discussed is BCL6; the disease is glioblastoma.